NCT03215745

Brief Summary

"To determine the efficacy of program of prevention of delirium in critically ill patients from the intensive care units of Bucaramanga and Floridablanca. Methods: The study will be a randomized controlled clinical trial in 600 critically ill patients recruited at 24 hours from arrival on the intensive care units of Bucaramanga and Floridablanca, without delirium, with ≥50% in the PREDELIRIC scale score, who comply with the inclusion and exclusion. The patients will be randomized in blocks to one of the two groups, intervention group (delirium prevention program, n=200) with control group (usual care; n= 400), the study will compare the incidence of delirium in both groups. Patients will be followed every day with Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) until the patient presents delirium, exit to hospitalization or death. Delirium prevention program includes individualized nonpharmacological interventions such as multisensory stimulation, cognitive stimulation, activate the functional and family involvement. The study has received ethical approval from the University of Santander"

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

9 months

First QC Date

July 10, 2017

Last Update Submit

October 25, 2017

Conditions

Keywords

DeliriumCritical CarePrevention & controlClinical Trial

Outcome Measures

Primary Outcomes (1)

  • Delirium

    For the measurement of delirium will be with the instrument Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) version in spanish.

    Within the first 30 days after admission at ICW

Study Arms (2)

Delirium prevention program

EXPERIMENTAL

Delirium prevention program involved a non-pharmacologic preventive interventions that will be focused in: Delirium prevention program includes individualized non-pharmacological interventions such as multisensory stimulation, cognitive stimulation, activate the functional and family involvement.

Behavioral: Delirium prevention program

Control group

NO INTERVENTION

Usual care

Interventions

Delirium prevention program Placard with the names of the care team and the calendar days; cognitively stimulating activities three times a day. Pictures, radio, robe. Visual aids large print books, with daily reinforcement of use Maintain adequate lighting opening blinds and curtains during the day, and darken their environment at night. Dissipation wax and special techniques of communication, with daily reinforcement of these adaptations. Go to the patient by name and tone of voice appropriate. Always listen. Use simple and clear language, face-to-face. Avoid excessive familiarity and childish. Promote family involvement in self-care and caregivers and the reorientation of the patient, contact with extended family during the stay.

Delirium prevention program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be older than 18 years
  • To have 24 hours of stay from the ingress to the intensive care unit
  • To expire with the criteria of intensive care unit defined by the investigative group (it presents itself with support, with invasive mechanical ventilation.
  • Patient without delirium in the revenue
  • Patients who present a percentage of prediction bigger than 50% according to the model PREDELIRIC

You may not qualify if:

  • Patients who scale of sedation RASS is applied and have like result of +4 and +5( scale that is applied systematically to the patient in intensive care unit)
  • Subjects with cognitive deficit or previous mental illness
  • Patients with precedents previous to delirium or in which the delirium measurement could be affected by its base condition
  • Patients with alcoholism precedents.
  • To be at the moment of the application of the instruments under substances that limit its skill to communicate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Los Comuneros Hospital University of Bucaramanga

Bucaramanga, Santander Department, 68006, Colombia

RECRUITING

Related Publications (1)

  • Contreras CCT, Esteban ANP, Parra MD, Romero MKR, Silva CGD, Buitrago NPD. Multicomponent nursing program to prevent delirium in critically ill patients: a randomized clinical trial. Rev Gaucha Enferm. 2021 Nov 3;42:e20200278. doi: 10.1590/1983-1447.2021.20200278. eCollection 2021. English, Spanish.

MeSH Terms

Conditions

Delirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Claudia C Torres, RN, MSc

    Universidad de Santander

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Claudia C Torres, RN, MSc

CONTACT

Astrid N Páez, RN, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2017

First Posted

July 12, 2017

Study Start

October 1, 2017

Primary Completion

July 1, 2018

Study Completion

December 1, 2018

Last Updated

October 27, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations